Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Chembio Diagnostics Stock Quote

Chembio Diagnostics (NASDAQ: CEMI)

Chembio Diagnostics Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
CEMI -26.73% -94.31% -43.62% -100%
S&P +22.34% +74.52% +11.78% +277%

Chembio Diagnostics Company Info

Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Medford, NY.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.